This database contains 162 studies, archived under the term: "Diagnostic Target Identification"
Click here to filter this large number of results.
A serum protein-based algorithm for the detection of Alzheimer disease
O'Bryant, Sid E.,
Xiao, Guanghua,
Barber, Robert,
Reisch, Joan,
Doody, Rachelle,
Fairchild, Thomas,
Adams, Perrie,
Waring, Steven,
Diaz-Arrastia, Ramon
Objective: To develop an algorithm that separates patients with Alzheimer disease (AD) from controls. Design: Longitudinal case-control study. Setting: The Texas Alzheimer’s Research Consortium project. Patients: We analyzed serum protein-based multiplex biomarker data from 197 patients diagnosed with AD and 203 controls. Main Outcome Measure: The total sample was randomized equally into training and test […]
The Computerized Self Test (CST): An interactive, internet accessible cognitive screening test for dementia
Dougherty, John H., Jr.,
Cannon, Rex L.,
Nicholas, Christopher R.,
Hall, Lorin,
Hare, Felicia,
Carr, Erika,
Dougherty, Andrew,
Janowitz, Jennifer,
Arunthamakun, Justin
The computer self test (CST) is an interactive, internet-based instrument designed to assess functional cognitive domains impaired by Alzheimer’s disease (AD) and mild cognitive impairment (MCI). This study consisted of 215 total subjects with a mean age of 75.24. The 84 cognitively impaired patients (excluding patients diagnosed as MCI) met all criteria set forth by […]
Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer’s disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment
Handels, R. L.,
Joore, M. A.,
Tran-Duy, A.,
Wimo, A.,
Wolfs, C. A.,
Verhey, F. R.,
Severens, J. L.
INTRODUCTION: The study aimed to determine the room for improvement of a perfect cerebrospinal fluid (CSF) biomarker and the societal incremental net monetary benefit of CSF in subjects with mild cognitive impairment (MCI) assuming a hypothetical disease-modifying Alzheimer’s disease (AD) treatment. METHODS: A decision model compared current practice to a perfect biomarker and to two […]
Wavelet coherence model for diagnosis of Alzheimer disease
This article presents a wavelet coherence investigation of electroencephalograph (EEG) readings acquired from patients with Alzheimer disease (AD) and healthy controls. Pairwise electrode wavelet coherence is calculated over each frequency band (delta, theta, alpha, and beta). For comparing the synchronization fraction of 2 EEG signals, a wavelet coherence fraction is proposed which is defined as […]
Diagnostic and economic evaluation of new biomarkers for Alzheimer’s disease: the research protocol of a prospective cohort study
Handels, Ron L.H.,
Aalten, Pauline,
Wolfs, Claire A.G.,
OldeRikkert, Marcel,
Scheltens, Philip,
Visser, Pieter Jelle,
Joore, Manuela A.,
Severens, Johan L.,
Verhey, Frans R.J.
Background: New research criteria for the diagnosis of Alzheimer’s disease (AD) have recently been developed to enable an early diagnosis of AD pathophysiology by relying on emerging biomarkers. To enable efficient allocation of health care resources, evidence is needed to support decision makers on the adoption of emerging biomarkers in clinical practice. The research goals […]
Detecting MCI and dementia in primary care: effectiveness of the MMS, the FAQ and the IQCODE corrected
Cruz-Orduña, Isabel,
Bellón, José M.,
Torrero, Pedro,
Aparicio, Esperanza,
Sanz, Ana,
Mula, Nieves,
Marzana, Garbiñe,
Begué, Concepción,
Cabezón, Dionisio,
Olazarán, Javier
Objectives: To study the yield of three instruments for detection of patients with cognitive impairment in primary care. To investigate whether combining tests is better for detecting impairment than applying them separately.; Methods: Seven primary care physicians (PCP) systematically recruited individuals aged over 49 years with a complaint or suspicion of cognitive impairment. The tests […]